BioSpace News Archive

Business

Prometheus Biosciences Reports First Quarter 2022 Financial Results and Highlights Recent Corporate Progress

Prometheus Biosciences, Inc. reported financial results for the quarter ended March 31, 2022 and highlighted recent corporate progress.

May 12, 2022
·
10 min read
Business

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2022Q1 2022 Product Sales Increased 46% over Q1 2021

ImmuCell Corporation announced its unaudited financial results for the quarter ended March 31, 2022.

May 12, 2022
·
11 min read
Business

Agile Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update

Agile Therapeutics, Inc., a women’s healthcare company, reported financial results for the three months ended March 31, 2022 and provided a corporate update.

May 12, 2022
·
14 min read
Business

Sientra Reports Seventh Consecutive Quarter of Record Growth for First Quarter 2022

Sientra, Inc., a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced its financial results for the first quarter that ended March 31, 2022.

May 12, 2022
·
14 min read
Business

Indaptus Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update

Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), today announces financial results for the first quarter ended March 31, 2022 and provides a corporate update.

May 12, 2022
·
11 min read
BioMidwest

Rockwell Medical Announces 1-for-11 Reverse Stock Split

Rockwell Medical, Inc., a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, announced that its Board of Directors has approved a 1-for-11 reverse split of the Company’s issued and outstanding common stock.

May 12, 2022
·
5 min read
Densitas® and Blackford Expand Partnership to Offer Breast Cancer Risk and Image Quality Solutions

Densitas® Inc., a global provider of A.I. technologies for digital mammography and breast screening announced an expansion of their partnership agreement with Blackford to integrate more of Densitas®' solutions with the Blackford Platform.

May 12, 2022
·
3 min read
Business

Formosa Pharmaceuticals and AimMax Therapeutics Announce Successful Top-Line Results from CPN-301 for the Treatment of Inflammation and Pain after Cataract Surgery

Formosa Pharmaceuticals, Inc. ( TWO.6838 ) and AimMax Therapeutics, Inc. ( United States ) report successful top-line results from CPN-301, the first of two pivotal Phase 3 clinical studies of APP13007.

May 12, 2022
·
3 min read
Deals

Hart-Scott-Rodino Waiting Period Expires for Halozyme’s Acquisition of Antares Pharma

Halozyme Therapeutics, Inc. announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, applicable to Halozyme’s proposed acquisition of Antares Pharma, Inc. has expired.

May 12, 2022
·
10 min read
Business

BrainStorm Strengthens Executive Team with Key Appointments in R&D and Legal

BrainStorm Cell Therapeutics Inc., a leading developer of cellular therapies for neurodegenerative diseases, announced two senior management appointments.

May 12, 2022
·
6 min read